ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,146Medicare Part D Prescriptions Filled, Including Refills

Rank: 140 out of 2035

$695K Total Retail Price of All Prescriptions

Rank: 141 out of 2035

719 Patients Receiving at Least One Drug in Part D
43%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 719 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

31% of this provider’s 719 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 4,415 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
HYDROCODONE-ACETAMINOPHEN 885 224 S3 1 2
SIMVASTATIN 299 196 2 1
AMLODIPINE BESYLATE 287 145 3 6
OMEPRAZOLE 285 121 4 5
FUROSEMIDE 261 121 5 7
TRAMADOL HCL 253 29 6 19
PREDNISONE 251 109 7 36
LISINOPRIL 231 96 8 3
ZOLPIDEM TARTRATE 192 65 9 21
ATENOLOL 187 120 10 10
LEVOTHYROXINE SODIUM 186 126 11 4
METFORMIN HCL 166 79 12 9
AZITHROMYCIN 163 67 13 39
CYCLOBENZAPRINE HCL 156 37 R 14 64
GABAPENTIN 155 45 15 14
RANITIDINE HCL 135 44 16 28
LOVASTATIN 134 100 17 33
METOPROLOL TARTRATE 134 97 17 8
VENTOLIN HFA 122 18 19 80
OXYCODONE HCL-ACETAMINOPHEN 117 18 S2 20 127
DOXYCYCLINE HYCLATE 112 23 21 129
CARISOPRODOL 103 0 R 22 57
LISINOPRIL-HYDROCHLOROTHIAZIDE 103 61 22 26
AMPHETAMINE SALT COMBO 102 0 S2 24 218
HYDROCHLOROTHIAZIDE 98 35 25 12
TRAZODONE HCL 92 20 26 50
PROAIR HFA 90 20 27 31
METHYLPREDNISOLONE 89 13 28 125
AMOXICILLIN 84 29 29 116
CLONIDINE HCL 78 24 30 61
ENALAPRIL MALEATE 76 48 31 60
CITALOPRAM HBR 74 28 32 20
METOPROLOL SUCCINATE 73 29 33 16
ALPRAZOLAM 69 33 34 109
IBUPROFEN 68 0 35 43
ROPINIROLE HCL 68 25 35 113
WARFARIN SODIUM 67 39 37 11
LEVOFLOXACIN 67 33 37 99
CIPROFLOXACIN HCL 67 37 37 63
SULFAMETHOXAZOLE-TRIMETHOPRIM 63 20 40 110
POTASSIUM CHLORIDE 60 15 41 18
CLINDAMYCIN HCL 59 25 42 388
METHYLPHENIDATE HCL 57 0 43 284
ATORVASTATIN CALCIUM 57 35 43 13
DIPHENOXYLATE-ATROPINE 56 21 45 455
CYMBALTA 56 0 45 59
TRIAMCINOLONE ACETONIDE 55 18 47 142
PROMETHAZINE HCL 54 0 R 48 106
CRESTOR 53 12 49 41
CEPHALEXIN 52 25 50 91
MORPHINE SULFATE ER 52 0 S2 50 86
GLIPIZIDE ER 52 14 50 131
CLOPIDOGREL 51 40 53 30
ISOSORBIDE MONONITRATE ER 50 39 54 32
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 21, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.